Impact of Vitreomacular Adhesion on Ranibizumab Mono- and Combination Therapy for Neovascular Age-Related Macular Degeneration-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Impact of Vitreomacular Adhesion on Ranibizumab Mono- and Combination Therapy for Neovascular Age-Related Macular Degeneration

Published:2014-08 Issue:2 Volume:158 Page:328-336.e1
ISSN:0002-9394
Container-title:American Journal of Ophthalmology
language:en
Short-container-title:American Journal of Ophthalmology

Author:

Waldstein Sebastian M.,Ritter Markus,Simader Christian,Mayr-Sponer Ulrike,Kundi Michael,Schmidt-Erfurth Ursula

Funder

National Foundation for Science and Technology Development

Austrian Federal Ministry of Economy, Family and Youth

Publisher

Elsevier BV

Subject

Ophthalmology

Reference37 articles.

1. Age-related macular degeneration;Lim;Lancet,2012

2. Development of ranibizumab, an anti-vascular endothelial growth factor antigen binding fragment, as therapy for neovascular age-related macular degeneration;Ferrara;Retina,2006

3. Ranibizumab for neovascular age-related macular degeneration;Rosenfeld;N Engl J Med,2006

4. Ranibizumab versus verteporfin for neovascular age-related macular degeneration;Brown;N Engl J Med,2006

5. An optical coherence tomography-guided, variable dosing regimen with intravitreal ranibizumab (Lucentis) for neovascular age-related macular degeneration;Fung;Am J Ophthalmol,2007

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Glaskörper bei der Therapie der exsudativen altersabhängigen Makuladegeneration;Die Ophthalmologie;2023-10

2. Reply;Retina;2023-07

3. THE IMPACT OF THE VITREOMACULAR INTERFACE ON FUNCTIONAL AND ANATOMICAL OUTCOMES IN DIABETIC MACULAR EDEMA TREATED WITH THREE DIFFERENT ANTI-VEGF AGENTS;Retina;2022-11

4. Influence of vitreomacular interface score on treatment outcomes of anti-VEGF therapy for neovascular age-related macular degeneration;International Journal of Retina and Vitreous;2021-12

5. Optical Coherence Tomography Prognostic Factors in AMD Patients with Peripapillary Choroidal Neovascularization;Ophthalmologica;2021-11-22

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3